TPEX:7871 Revenue

In the year 2025, Elixiron Immunotherapeutics (Cayman) Limited had annual revenue of 50.29M TWD with 6,162.39% growth. Elixiron Immunotherapeutics (Cayman) Limited had revenue of 223.00K in the half year ending June 30, 2025.

Revenue

50.29M

Revenue Growth

+6,162.39%

P/S Ratio

187.72

Revenue / Employee

n/a

Employees

n/a

Market Cap

9.44B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	50.29M	49.48M	6,162.39%
Dec 31, 2024	803.00K	-24.89M	-96.88%
Dec 31, 2023	25.70M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition